Inhibition of TGF-β1 suppresses motility and invasiveness of oral squamous cell carcinoma cell lines via modulation of integrins and down-regulation of matrix-metalloproteinases

Oncology Reports

Volumn 21, Issue 1, 2009, Pages 205-210

  Takayama, Sayaka ^a   Hatori, Masashi ^a   Kurihara, Yuji ^a   Kinugasa, Yuriko ^a   Shirota, Tatsuo ^a   Shintai, Satoru ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

Integrin; Matrix metalloproteinase; Squamous cell carcinoma; TGF 1

Indexed keywords

ALPHA5 INTEGRIN; BETA1 INTEGRIN; BETA6 INTEGRIN; GELATINASE A; GELATINASE B; INTEGRIN; MATRIX METALLOPROTEINASE; PHOSPHOTRANSFERASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1 KINASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR; ENZYME INHIBITOR;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; MOUTH CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; UPREGULATION; WESTERN BLOTTING; CELL MOTION; CELL PROLIFERATION; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; MOUTH TUMOR; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; ENZYME INHIBITORS; HUMANS; INTEGRINS; MATRIX METALLOPROTEINASES; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 61449524302     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000209     Document Type: Article

References (26)

1. Wright JA, Turley EA and Greenberg H: Transforming growth factor beta and fibroblast growth factor as promoters of tumor progression to malignancy. Oncogenesis 4: 473-492, 1993.
2. Hasegawa Y, Takanashi S, Kanehira Y, Tsushima T, Imai T and Okumura K: Transforming growth factor-β 1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma. Cancer 91: 964-971, 2001.
3. Tsushima H, Kawata S, Tamura S, et al: High levels of transforming growth factor β 1 in patients with colorectal cancer: association with disease progression. Gastroenterology 110: 375-382, 1996.
4. Shim KS, Kim KH, Han WS and Park EB: Elevated serum levels of transforming growth factor-β 1 in patients with colorectal carcinoma: its association with tumor progression and its significant decrease after curative surgical resection. Cancer 85: 554-561, 1999.
5. Saito H, Tsujitani S and Oka S, et al: The expression of transforming growth factor-β 1 is significantly correlated with the expression of vascular endothelial growth factor and poor prognosis of patients with advanced gastric carcinoma. Cancer 86: 1455-1462, 1999.
6. Wikstrom P, Stattin P, Franck-Lissbrant I, et al: Transforming growth factor β 1 is associated with angiogenesis, metastasis, and poor clinical outcome in prostate cancer. Prostate 37: 19-29, 1998.
7. Young MR: Protective mechanisms of head and neck squamous cell carcinomas from immune assault. Head Neck 28: 462-470, 2006.
8. Aida T, Arai J, Irie T, Yoshizawa M, et al: Establishment and characterization of human oral squamous cell carcinoma cell line with highly lymph node metastatic potential. J Jpn Soc Oral Tumor 13: 66-72, 2001.
9. Takahashi K, Kanazawa H, Akiyama Y, et al: Establishment and characterization of a cell line (SAS) from poorly differentiated human squamous cell carcinoma of the tongue. Kokubyo Gakkai Zasshi 38: 20-28, 1989.
10. Shaw RJ, Paez JG, Curto M, et al: The nf2 tumor suppressor, merlin, functions in Rac-dependent signaling. Dev Cell 1: 63-72, 2001.
11. Friess H, Yamanaka Y, Buchler M, et al: Enhanced expression of transforming growth factor β isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology 105: 1846-1856, 1993.
12. Walker RA and Dearing SJ: Transforming growth factor β 1 in ductal carcinoma in situ and invasive carcinomas of the breast. Eur J Cancer 28: 641-644, 1992.
13. Friedman E, Gold LI, Klimstra D, et al: High levels of transforming growth factor β 1 correlate with disease progression in human colon cancer. Cancer Epidemiol Biomarkers Prev 4: 549-554, 1995.
14. Dalal BI, Keown PA and Greenberg AH: Immunocytochemical localization of secreted transforming growth factor-β 1 to the advancing edges of primary tumors and to lymph node metastases of human mammary carcinoma. Am J Pathol 143: 381-389, 1993.
15. Picon A, Gold LI, Wang J, et al: A subset of metastatic human colon cancers expresses elevated levels of transforming growth factor β 1. Cancer Epidemiol Biomarkers Prev 7: 497-504, 1998.
16. Liotta LA and Stetler-Stevenson WG: Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res 51: 5054-5059, 1991.
17. Lukashev ME and Werb Z: ECM signaling: orchestrating cell behaviour and misbehaviour. Trends Cell Biol 8: 437-441, 1998.
18. Chambers AF and Matrisian LM: Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 89: 1260-1270, 1997.
19. Yang C, Zeisberg M, Lively JC, et al: Integrin alpha1beta1 and alpha2beta1 are the key regulators of hepatocarcinoma cell invasion across the fibrotic matrix microenvironment. Cancer Res 63: 8312-8317, 2003.
20. Robinson CM, Stone AM, Shields JD, et al: Functional significance of MMP-2 and MMP-9 expression by human malignant oral keratinocyte cell lines. Arch Oral Biol 48: 779-786, 2003.
21. Bernardo MM and Fridman R: TIMP-2 (tissue inhibitor of metalloproteinase-2) regulates MMP-2 (matrix metalloproteinase-2) activity in the extracellular environment after pro-MMP-2 activation by MT1 (membrane type 1)-MMP. Biochem J 374: 739-745, 2003.
22. Duffy MJ: The role of proteolytic enzymes in cancer invasion and metastasis. Clin Exp Metast 10: 145-155, 1992.
23. Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM and Shafie S: Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284: 67-68, 1980.
24. Miranti CK and Brugge JS: Sensing the environment: a historical perspective on integrin signal transduction. Nat Cell Biol 4: E83-E90, 2002.
25. Giancotti FG and Ruoslahti E: Integrin signaling. Science 285: 1028-1032, 1999.
26. Hynes RO: Integrins: bidirectional, allosteric signaling machines. Cell 110: 673-687, 2002.